This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2016.
Company Filing History:
1 out of 834,411 Years Active: 2016
Title: Innovations of Amber Atta in Diabetes Research
Introduction
Amber Atta is a notable inventor based in Karachi, Pakistan. She has made significant contributions to the field of diabetes research through her innovative work. Her research focuses on developing solutions to reduce complications associated with diabetes.
Latest Patents
Amber Atta holds a patent for her work titled "Anthranilic acid derivatives: novel inhibitors of advanced glycation end-products (AGEs) formation." This patent addresses the use of anthranilic acid derivatives to inhibit the formation of advanced glycation end products, which are known to contribute to complications in diabetes. She has 1 patent to her name.
Career Highlights
Throughout her career, Amber has demonstrated a commitment to advancing medical research. Her work has been recognized for its potential impact on improving the quality of life for individuals living with diabetes.
Collaborations
Amber has collaborated with esteemed colleagues in her field, including Atta-ur-Rahman and Kahlid Mohammed Khan. These collaborations have further enriched her research and contributed to the advancement of diabetes treatment options.
Conclusion
Amber Atta's innovative work in diabetes research highlights her dedication to finding solutions for complex health issues. Her contributions are paving the way for future advancements in the field.